Russian Missile Attack on Ukraine Escalates Geopolitical Risks Raising Market Uncertainty Treasury Yield Surge Challenges RiskFree Status Creates Potential for Intermediate BBB and HighYield Bonds The Pitfalls of Chasing High Returns Why LongTerm Strategy Matters USIran Standoff Deepens After Trump Rejects Counteroffer Raising Risks for Global Energy Markets JPMorgans Annual Summer Reading List Highlights AI Leadership and Lemons for Wealthy Clients SP 500 Flat as Consumer Discretionary Strength Offsets Energy and Tech Weakness PubMatic PUBM Q1 2026 Earnings EPS Beats Estimates as AdTech Efficiency Drives Positive Surprise Amtech Systems Q1 2026 Earnings Strong Profitability Surprise Amid Revenue Discretion Innoviva INVA Q1 2026 Earnings EPS Misses Estimates by Over 112 Stock Declines CENTA Q1 2026 Earnings EPS Surpasses Estimates by 154 MFA Financial Inc 8875 Senior Notes due 2029 MFAN Q1 2026 Earnings Slight EPS Miss Amid Stable Bond Performance BillionToOne BLLN Q1 2026 Earnings Strong EPS Beat Overshadows Missing Revenue Details Greenwich LifeSciences GLSI Inches Higher Amid Calm Trading Session SB Financial Group Inc SBFG Holds Steady at 215 as Key Levels Provide Bounds Barinthus Biotherapeutics BRNS Edges Higher Small Uptick in LowPriced Stock WM Technology MAPS Holds Key Support Amid Modest Decline TechnipFMC FTI Advances Modestly Holds Above Key Support Fox Corporation Shares Decline in Q1 After Prior Period of Strong Gains Surging Gas Prices Disproportionately Burden LowIncome Households New York Fed Study Reveals Oil Prices Edge Higher Amid Skepticism Over USIran Negotiations Ukrainian Drone Strike Ignites Fire at Key Russian Oil Export Terminal Escalating Energy Infrastructure Risks Expert View Buy on Dips Strategy May Be Avoided Amid Market Volatility Says HDFC Securities Analyst Burberry Shares Climb on Report of Potential Moncler Takeover Bid Why People Skills Matter in Business Lessons From a Child Therapists 6 Key Phrases BFS Q1 2026 Earnings Massive EPS Beat Drives Positive Stock Reaction Mineralys Therapeutics MLYS Sees Slight Decline Maintains Position Between Key Technical Levels